A single dose of the DENV-1 candidate vaccine rDEN1Δ30 is strongly immunogenic and induces resistance to a second dose in a randomized trial.

by Anna P Durbin, Stephen S Whitehead, Donna Shaffer, Dan Elwood, Kimberli Wanionek, Bhavin Thumar, Joseph E Blaney, Brian R Murphy, Alexander C Schmidt
Published 2011-08-01

Phase 1 trial of the Plasmodium falciparum blood stage vaccine MSP1(42)-C1/Alhydrogel with and without CPG 7909 in malaria naïve adults.

by Ruth D Ellis, Laura B Martin, Donna Shaffer, Carole A Long, Kazutoyo Miura, Michael P Fay, David L Narum, Daming Zhu, Gregory E D Mullen, Siddhartha Mahanty, Louis H Miller, Anna P Durbin
Published 2010-01-01

Phase 1 study in malaria naïve adults of BSAM2/Alhydrogel®+CPG 7909, a blood stage vaccine against P. falciparum malaria.

by Ruth D Ellis, Yimin Wu, Laura B Martin, Donna Shaffer, Kazutoyo Miura, Joan Aebig, Andrew Orcutt, Kelly Rausch, Daming Zhu, Anders Mogensen, Michael P Fay, David L Narum, Carole Long, Louis Miller, Anna P Durbin
Published 2012-01-01

Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.

by Yimin Wu, Ruth D Ellis, Donna Shaffer, Erica Fontes, Elissa M Malkin, Siddhartha Mahanty, Michael P Fay, David Narum, Kelly Rausch, Aaron P Miles, Joan Aebig, Andrew Orcutt, Olga Muratova, Guanhong Song, Lynn Lambert, Daming Zhu, Kazutoyo Miura, Carole Long, Allan Saul, Louis H Miller, Anna P Durbin
Published 2008-07-01